Some determinants of entry into the rapeutic drug markets

This paper investigates empirically some determinants of entry into the U.S. pharmaceutical industry during the period 1964–1974. The statistical findings of the study are consistent with a priori expectations. Market growth is found to provide incentives for entry, Product differentiation, market concentration, and drug innovation are found to be significant barriers to entry into drug markets.